This system consists of a capture antibody against GzmA followedby incubation with probe-1, which presents a high specificity to determinethe enzymatic activity of GzmA, as validated using pure proteasesand samples from GzmAKO mice suffering from different inflammatorydiseases like sepsis and HLH. This evidence concerns the gene GZMA and hemophagocytic syndrome.